Results 271 to 280 of about 2,243,647 (283)

Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies

Cancer Letters, 2023
Nagaraju Gp
exaly  

ERK‐mediated transcriptional activation of Dicer is involved in gemcitabine resistance of pancreatic cancer

Journal of Cellular Physiology, 2021
Hsin-An Chen, Ching-Feng Chiu, Ta-Hsien Chuang   +2 more
exaly  

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer

Cancer Cell, 2017
John Asara, Aneesha Dasgupta, Vinee Purohit   +2 more
exaly  

MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer

Tumor Biology, 2015
Xi-Chun Hu, Zhong-Hua Tao, Ting Li
exaly  

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

British Journal of Cancer, 2013
Yuichiro Doki, Hidetoshi Eguchi, A Tomokuni   +2 more
exaly  

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers

Biomolecules, 2020
Yi-Ru Pan, Chiao-En Wu, John Lunec
exaly  

Gemcitabine-resistant pancreatic cancer: a second-line option

The Lancet, 2016
Helmut, Oettle, Thorsten, Lehmann
openaire   +2 more sources

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

International Journal of Cancer, 2007
Jiro Okami
exaly  

Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Sciences, 2011
exaly  

Sensitizing of gemcitabine-resistant human leukemia cells by stearoyl gemcitabine nanoparticles .

Nanomedicine (London, England), 2012
openaire   +1 more source